YETI:NYSEYETI Holdings, Inc. Analysis
Data as of 2026-09-19 - not real-time
$42.21
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At $42.21, YETI Holdings, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it lost 18.6%. RSI sits at 47.9, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $39.04 up to resistance at $44.40.
Multiples put this in fair territory at a P/E of 18.5. Sell-side targets cluster 29.2% above the current quote. Revenue is growing at 8.5% on a 9.2% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 43.2%, a beta of 1.25 and a maximum drawdown of 30.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.
Multiples put this in fair territory at a P/E of 18.5. Sell-side targets cluster 29.2% above the current quote. Revenue is growing at 8.5% on a 9.2% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 43.2%, a beta of 1.25 and a maximum drawdown of 30.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 4/10 conviction on the long call.
Top Market Events
What Happened? Shares of outdoor lifestyle products brand NYSE:YETI fell 12.7% in the afternoon session after the...ADVFN1monYETI Raises 2026 Earnings Outlook After Strong Q2 Profit BeatYETI Holdings NYSE:YETI delivered second-quarter...Net Sales Increase 9%Raises Full Year 2026 EPS OutlookReturns $130 Million to Shareholders Through Share...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 44.47
- MACD momentum is positive
- 30-day price change of -18.6%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 44.47
- Analyst targets imply +29.2% versus the current price
- 30-day volatility of 43.2%
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Analyst targets imply +29.2% versus the current price
- P/E ratio of 18.5
- Return on equity of 25.3%
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin9.24%
P/E Ratio18.5
ROE25.32%
ROA11.32%
Debt/Equity41.52
P/B Ratio5.1
Op. Cash Flow$303.6M
Free Cash Flow$127.4M
Technical Analysis
TrendNeutral
RSI47.9
Support$39.04
Resistance$44.40
MA 20$41.24
MA 50$46.08
MA 200$44.47
MACDBullish
VolumeIncreasing
Fear & Greed Index94.98
Valuation
Fair Value$28.26
Target Price$54.53
Upside/Downside29.20%
GradeFair
TypeGrowth
Risk Assessment
Beta1.25
Volatility43.25%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.